TELOS CORP
For the period ended Sep 30, 2026. Filed Nov 9, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 9, 2026
TLS$7.67+7.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
| For the Nine Months Ended | ||
|---|---|---|
| September 30, 2026 | September 30, 2025 | |
| (in thousands) | ||
| Cash flows from operating activities: | ||
| Net income (loss) | $7,119 | $(20,235) |
| Adjustments to reconcile net income (loss) to cash flows from operations: | ||
| Stock-based compensation | 9,195 | 24,193 |
| Depreciation and amortization | 10,248 | 8,022 |
| Loss on disposal of fixed assets | 52 | 1 |
| Provision for inventory obsolescence | 42 | — |
| Amortization of debt issuance costs | 26 | 52 |
| Deferred income taxes | 6 | 41 |
| Provision for doubtful accounts | 1 | 3 |
| Changes in other operating assets and liabilities: | ||
| Accounts receivable | (6,731) | (1,254) |
| Inventories | (1,825) | 1,081 |
| Prepaid expenses, deferred program expenses, other current assets, other assets | 8,072 | 701 |
| Accounts payable | (2,832) | (1,263) |
| Accrued compensation and benefits | 1,466 | 1,420 |
| Contract liabilities | 4,756 | 6,894 |
| Accrued liabilities and other liabilities | (2,662) | 2,546 |
| Net cash provided by operating activities | 26,933 | 22,202 |
| Cash flows from investing activities: | ||
| Capitalized software development costs | (6,075) | (6,496) |
| Purchases of property and equipment, net | (477) | (709) |
| Net cash used in investing activities | (6,552) | (7,205) |
| Cash flows from financing activities: | ||
| Payments under finance lease obligations | (1,509) | (1,393) |
| Payment of tax withholding related to net share settlement of equity awards | (7,632) | (1,600) |
| Repurchases of common stock | (12,637) | (7,639) |
| Payments for debt issuance costs | (21) | — |
| Proceeds from exercise of stock options | — | 108 |
| Net cash used in financing activities | (21,799) | (10,524) |
| Net change in cash, cash equivalents, and restricted cash | (1,418) | 4,473 |
| Cash, cash equivalents, and restricted cash, beginning of period | 53,320 | 54,717 |
| Cash, cash equivalents, and restricted cash, end of period | $51,902 | $59,190 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.